Trials / Completed
CompletedNCT01337466
Biodistribution and Dosimetry Evaluation of [124I]FIAU
Biodistribution and Dosimetry of [124i]FIAU in Patients With Prosthetic Joint Infection of The Knee or Hip and Healthy Subjects Using PET-CT Scanning
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- BioMed Valley Discoveries, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This protocol will evaluate the biodistribution and dosimetry of \[124I\]FIAU in both healthy volunteers and patients with prosthetic joint infections. This pilot study will also investigate the safety and tolerability of \[124I\]FIAU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [124I]FIAU | This is a single dose study of 2 mCi \[124I\]FIAU in healthy volunteers or subjects with prosthetic joint infection of the knee or hip who will undergo serial PET-CT scanning. |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2012-12-01
- Completion
- 2013-03-01
- First posted
- 2011-04-19
- Last updated
- 2013-06-27
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01337466. Inclusion in this directory is not an endorsement.